New-Onset Arrhythmia After TAVR: How New, Really?

Week-long continuous ECG monitoring was a worthwhile addition to the workup before transcatheter aortic valve replacement (TAVR), a small study suggested. Monitoring with the wearable CardioSTAT device over 7 days revealed arrhythmic events in 51 of 106 TAVR candidates, changing the treatment plan for 14 of them (such as starting anticoagulation) in the 3 months…Continue Reading